Navigation Links
Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
Date:4/1/2008

osition of clinical trials, the report reveals that only 25 percent of those taking part in cancer studies in 2003 were over 65 years of age. Older Americans are also routinely left out of clinical trials studying diseases associated with aging, such as Alzheimer's disease, arthritis, and incontinence.

At the same time, the report finds that the biomedical research community has been unsuccessful in resolving the under-representation of women, older adults, and racial and ethnic minorities in clinical research studies, despite many efforts to improve the performance in this area. One study cited in the report that examined the composition of clinical trials testing new cancer drugs between 1995-1999 found less than 10 percent of the patients studied collectively represented African Americans, Asian/Pacific Islanders, Hispanics and Native Americans.

"Although disparities in clinical trials has been discussed and debated extensively, this problem has generally been under-addressed and, as a result, has received little direct, systematic, or sustained intervention," said Armin D. Weinberg, Ph.D., Director of Baylor College of Medicine's Chronic Disease Prevention and Control Research Center and EDICT's Principal Investigator. "This report is intended as a nationwide call to action and is provided as a blueprint for removing the barriers to clinical trial participation, which is a critical step to improving the health status of all Americans."

More than an issue of fairness, the EDICT report associates better designed clinical research studies with the increased ability of scientists to catalog and understand the influence of genetic and non-genetic factors on individual and group responses to treatments, now possible as a result of the successful sequencing of the human genome. Findings from the large amount of genetic data generated to date show that more than 90 percent of the observed genetic variations occur within rather than between gro
'/>"/>

SOURCE Eliminating Disparities in Clinical Trials
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Cancer Cure Coalition Proposes Major Changes at the FDA
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Penn Research Shows Transcranial Magnetic Stimulation Effective in Treating Major Depression
6. Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo
7. Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
8. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
9. Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
10. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
11. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  The need to add ... continuum was highlighted prominently at the 108 th ... (AUA), in San Diego.  According to SonaCare Medical, ... ultrasound (HIFU) technology, the need for image-guided technologies ... urologists to consider minimally invasive ablative treatments, was ...
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
(Date:5/23/2013)... 2013  Hologic, Inc. (Hologic or the Company) ... manufacturer and supplier of premium diagnostics, medical imaging ... serving the healthcare needs of women, today announced ... U.S. clinical practice comparing breast cancer screening with ... 2D mammography alone showed a significant reduction in ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
(Date:5/23/2013)... Internationally recognized as one of the top developmental ... years, Coach Nick Saviano’s proven methodology has ... Slam winners, World #1’s; Junior Wimbledon, US Open, French ... Champions, 8 Foreign National Junior Champions and more than ... and Eddie Herr winners - and boasts a 100% ...
(Date:5/23/2013)... 2013 Orange County film studio and visual ... light leaks for Apple's Final Cut Pro X ... you no longer have to worry about matching up the ... shot," Said Christina Austin, CEO of Pixel Film Studios, "You ... natural look." , ProLeak from Pixel Film Studios allows users ...
(Date:5/23/2013)... 2013 Today, Zane Benefits, Inc. published ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution plans and health reimbursement ... question from employees is “does my employer have to ... necessarily. The health care reform law, called the Affordable ...
(Date:5/23/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Glucosamine ... hip and knee osteoarthritis may have an unexpected side ... small new study of older adults suggests. ... pressure (IOP) or pressure inside the eye. Left untreated, ... In the new study of 17 ...
(Date:5/23/2013)... Science published an article about bexarotene as ... important starting point for further Alzheimer,s research. The research ... VIB and KU Leuven in collaboration with the ... scientists at Janssen Pharmaceutica, Beerse, also tested this candidate ... were different, as were those of two American study ...
Breaking Medicine News(10 mins):Health News:Internationally Respected Tennis Coach, Nick Saviano Opens Summer Training Registration 2Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2Health News:Zane Benefits Publishes New Information on the Employer Mandate 2Health News:Zane Benefits Publishes New Information on the Employer Mandate 3Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:New insights contradict promising Alzheimer's research 2
... more difficult to recognize and treat epilepsy in old ... Deutsches rzteblatt International ( Dtsch Arztebl Int ... Epilepsy Center of Johannes Gutenberg University in Mainz, Germany, ... therapeutic options. , It is often not possible ...
... Pharmaceuticals, Inc. (Nasdaq: TSPT ), a specialty ... proprietary products that address important therapeutic needs in the ... for its fourth quarter 2008 on Monday, March 23, ... the results will begin at 5:00 p.m. ET (2:00 ...
... benefit from tonal training , , FRIDAY, March 13 (HealthDay ... emotion in speech and other sounds, a finding that ... problems and impaired emotional perception. , "Quickly and ... translates across all arenas, whether in the predator-infested jungle ...
... CONSHOHOCKEN, Pa., March 13 Apollo Health Street has ... Payer segment in the prestigious Black Book of Outsourcing ... Apollo Health Street, states, "We appreciate the recognition from ... is an independent validation of our commitment to excellence.""The ...
... in the Schering-Plough Corporation Securities Litigation class action suit ... COURT, DISTRICT OF NEW JERSEY, ... MASTER FILE NO. 01-CV-0829 (KSH/MF), , ... SECURITIES DURING THE PERIOD FROM MAY 9, 2000 THROUGH ...
... Study shows giving up your keys has its down sideSAN ... The Journals of Gerontology (Medical Sciences) indicate that convincing older ... such a good idea.The study of 660 adults aged 63 ... to six times more likely to die over a three-year ...
Cached Medicine News:Health News:Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results 2Health News:Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results 3Health News:Musicians' Brains Tuned to Emotions in Sound 2Health News:Apollo Health Street Has Earned the Number One Spot in the Healthcare Payer Segment for BPO Services 2Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 2Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 3Health News:Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M. 4Health News:Drive or Die 2Health News:Drive or Die 3
... rate: 80 cc/minute. Pore ... filtering fluids at flow ... bi-directional membrane support rated ... psi) via prefilled syringe ...
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Straight, right side cutting, 1.5 mm x 4 mm bite, length of shaft 115 mm, overall length 6.3 inches....
Backward cutting, 3 mm x 7 mm bite, length of shaft 100 mm, overall length 7 inches....
Medicine Products: